
|Articles|January 24, 2022
This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28
Author(s)Lindsey Carr, Editor
A look at what's coming to Contemporary OB/GYN® this week.
Advertisement
The effect of eating disorders in pregnancy on neurodevelopmental risk in infants
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics partners with Afayxs to expand access to Twirla®
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Phase 1 trial shows promise for triple-negative breast cancer vaccine
2
Broader genetic testing improves breast cancer risk detection
3
Top FDA approvals in women's health in 2025
4
COVID-19 vaccination during pregnancy reduces severe illness and preterm birth
5











